Mainz Biomed B.V.

NASDAQ: MYNZ · Real-Time Price · USD
1.76
0.07 (4.14%)
At close: Aug 15, 2025, 3:59 PM
1.69
-3.98%
After-hours: Aug 15, 2025, 05:30 PM EDT

Mainz Biomed B.V. Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-21.65M -26.3M -26.39M -11.69M
Depreciation & Amortization
1.02M 866.41K 379.8K 69.93K
Stock-Based Compensation
1.14M 4.01M 9.82M 6.43M
Other Working Capital
-42.34K -300.22K -53.79K -162.83K
Other Non-Cash Items
2.36M -450.53K 1.85M 2.11M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
51.75K -64.63K -437.4K -138.62K
Operating Cash Flow
-17.09M -21.94M -14.77M -3.22M
Capital Expenditures
-254.95K -1.9M -658.48K -16.7K
Cash Acquisitions
32.78K n/a n/a 1.22M
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-126.65K -700K n/a 1.22M
Investing Cash Flow
-198.82K -1.9M -658.48K 1.2M
Debt Repayment
3.13M 7.83M -197.94K 185.37K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-295.25K n/a 24.14M n/a
Financial Cash Flow
16.6M 14.23M 23.94M 10.61M
Net Cash Flow
-835.25K -10.07M 8.41M 8.6M
Free Cash Flow
-17.34M -23.84M -15.43M -3.24M